MARY SANDS: Open Payments
NPI 1093729444 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$404 in 20 payments from 6 companies in 2025. Trend: 2023 $30,128 · 2024 $936 · 2025 $404
Food & beverage: $404
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $199 |
| ABBVIE INC. | 6 | $112 |
| Alexion Pharmaceuticals, Inc. | 1 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
Products named: ELIQUIS, DALVANCE, ULTOMIRIS, XIFAXAN, AVYCAZ, ZERBAXA, EMBLAVEO, JARDIANCE.
Industry payments across NC — which companies pay providers there.
